{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:11:44Z","timestamp":1792642304925,"version":"4.5.0"},"reference-count":145,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2025,3]]},"abstract":"\n ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the<\/jats:italic>\n \n ASCO Guidelines Methodology Manual<\/jats:italic>\n <\/jats:ext-link>\n . ASCO Guidelines follow the<\/jats:italic>\n \n ASCO Conflict of Interest Policy for Clinical Practice Guidelines<\/jats:italic>\n <\/jats:ext-link>\n .\n <\/jats:p>\n \n \n Clinical Practice Guidelines and other guidance (\u201cGuidance\u201d) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by clinicians and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and analysis of relevant literature and is not intended as a statement of the standard of care. ASCO does not endorse third-party drugs, devices, services, or therapies and assumes no responsibility for any harm arising from or related to the use of this information. See complete disclaimer in\n Appendix 1<\/jats:xref>\n and\n 2<\/jats:xref>\n (online only) for more\n <\/jats:italic>\n .\n <\/jats:p>\n \n PURPOSE<\/jats:title>\n To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal cancer (epithelial ovarian cancer [EOC]).<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n A multidisciplinary Expert Panel convened and updated the systematic review.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n Sixty-one studies form the evidence base.<\/jats:p>\n <\/jats:sec>\n \n RECOMMENDATIONS<\/jats:title>\n Patients with suspected stage III-IV EOC should be evaluated by a gynecologic oncologist, with cancer antigen 125, computed tomography of the abdomen and pelvis, and chest imaging included. All patients with EOC should be offered germline genetic and somatic testing at diagnosis. For patients with newly diagnosed advanced EOC who are fit for surgery and have a high likelihood of achieving complete cytoreduction, PCS is recommended. For patients fit for PCS but deemed unlikely to have complete cytoreduction, NACT is recommended. Patients with newly diagnosed advanced EOC and a high perioperative risk profile should receive NACT. Before NACT, patients should have histologic confirmation of invasive ovarian cancer. For NACT, a platinum-taxane doublet is recommended. Interval cytoreductive surgery (ICS) should be performed after \u2264four cycles of NACT for patients with a response to chemotherapy or stable disease. For patients with stage III disease, good performance status, and adequate renal function treated with NACT, hyperthermic intraperitoneal chemotherapy may be offered during ICS. After ICS, chemotherapy should continue to complete a six-cycle treatment plan with the optional addition of bevacizumab. Patients with EOC should be offered US Food and Drug Administration\u2013approved maintenance treatments. Patients with progressive disease on NACT should have diagnosis reconfirmed via tissue biopsy. Patients without previous comprehensive genetic or molecular profiling should be offered testing. Treatment options include alternative chemotherapy regimens, clinical trials, and\/or initiation of end-of-life care.<\/jats:p>\n \n Additional information is available at\n www.asco.org\/gynecologic-cancer-guidelines<\/jats:ext-link>\n .\n <\/jats:p>\n This guideline has been endorsed by the Society of Gynecologic Oncology.<\/jats:p>\n <\/jats:sec>","DOI":"10.1200\/jco-24-02589","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T15:59:07Z","timestamp":1737561547000},"page":"868-891","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":107,"title":["Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update"],"prefix":"10.1200","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2174-3693","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Gaillard","sequence":"first","affiliation":[{"name":"Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-713X","authenticated-orcid":false,"given":"Christina","family":"Lacchetti","sequence":"additional","affiliation":[{"name":"American Society of Clinical Oncology, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0852-803X","authenticated-orcid":false,"given":"Deborah K.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-9884","authenticated-orcid":false,"given":"William A.","family":"Cliby","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell I.","family":"Edelson","sequence":"additional","affiliation":[{"name":"Jefferson Health-Abington, Willow Grove, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin A.","family":"Garcia","sequence":"additional","affiliation":[{"name":"LSU School of Medicine, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-5109","authenticated-orcid":false,"given":"Rahel G.","family":"Ghebre","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School & St Paul's Hospital Millennium Medical School, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6729-4571","authenticated-orcid":false,"given":"Gregory M.","family":"Gressel","sequence":"additional","affiliation":[{"name":"Corewell Health Cancer Center and Michigan State University, Grand Rapids, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Lesnock","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-7463","authenticated-orcid":false,"given":"Larissa A.","family":"Meyer","sequence":"additional","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-0718","authenticated-orcid":false,"given":"Kathleen N.","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Oklahoma, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-4554","authenticated-orcid":false,"given":"Roisin E.","family":"O'Cearbhaill","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Olawaiye","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-343X","authenticated-orcid":false,"given":"Ritu","family":"Salani","sequence":"additional","affiliation":[{"name":"University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dee","family":"Sparacio","sequence":"additional","affiliation":[{"name":"Patient Representative, Hightstown, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1994","authenticated-orcid":false,"given":"Willemien J.","family":"van Driel","sequence":"additional","affiliation":[{"name":"Netherlands Cancer Institute, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-4470","authenticated-orcid":false,"given":"William P.","family":"Tew","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_9_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02765"},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31090417"},{"key":"e_1_3_9_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908806"},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62223-6"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.01.017"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.05.017"},{"key":"e_1_3_9_8_2","first-page":"Cd005343","article-title":"Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer","volume":"7","author":"Coleridge SL","year":"2021","unstructured":"Coleridge SL, Bryant A, Kehoe S, et al: Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev 7:Cd005343, 2021","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.39893"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.6907"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02960"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01934"},{"key":"e_1_3_9_15_2","first-page":"341","article-title":"Laparoscopy vs. laparotomy for advanced ovarian cancer: A systematic review of the literature","volume":"110","author":"Gueli AS","year":"2019","unstructured":"Gueli AS, Capozzi VA, Rosati A, et al: Laparoscopy vs. laparotomy for advanced ovarian cancer: A systematic review of the literature. Minerva Med 110:341-357, 2019","journal-title":"Minerva Med"},{"key":"e_1_3_9_16_2","first-page":"Cd009786","article-title":"Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer","volume":"3","author":"van de Vrie R","year":"2019","unstructured":"van de Vrie R, Rutten MJ, Asseler JD, et al: Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer. Cochrane Database Syst Rev 3:Cd009786, 2019","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e82"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001640"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.02.020"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.08.014"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00396-0"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708618"},{"key":"e_1_3_9_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.0143"},{"key":"e_1_3_9_24_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-11087-7"},{"key":"e_1_3_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.09.036"},{"key":"e_1_3_9_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000256"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa145"},{"key":"e_1_3_9_28_2","first-page":"1319","article-title":"Model for prediction of optimal debulking of epithelial ovarian cancer","volume":"19","author":"Arab M","year":"2018","unstructured":"Arab M, Jamdar F, Sadat Hosseini M, et al: Model for prediction of optimal debulking of epithelial ovarian cancer. Asian Pac J Cancer Prev 19:1319-1324, 2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"e_1_3_9_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-020-01170-6"},{"key":"e_1_3_9_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-0614-1"},{"key":"e_1_3_9_31_2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e65"},{"key":"e_1_3_9_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.23654"},{"key":"e_1_3_9_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2018-000054"},{"key":"e_1_3_9_34_2","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2020.02.19"},{"key":"e_1_3_9_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03336-2"},{"key":"e_1_3_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.07.020"},{"key":"e_1_3_9_37_2","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2021-0013"},{"key":"e_1_3_9_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.010"},{"key":"e_1_3_9_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.02.020"},{"key":"e_1_3_9_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.01.013"},{"key":"e_1_3_9_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-020-05188-x"},{"key":"e_1_3_9_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06235-y"},{"key":"e_1_3_9_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2019.04.005"},{"key":"e_1_3_9_44_2","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000396"},{"key":"e_1_3_9_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0488-2"},{"key":"e_1_3_9_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10122553"},{"key":"e_1_3_9_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.03.007"},{"key":"e_1_3_9_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-018-0415-y"},{"key":"e_1_3_9_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.10.017"},{"key":"e_1_3_9_50_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08649-6"},{"key":"e_1_3_9_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.10.034"},{"key":"e_1_3_9_52_2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e17"},{"key":"e_1_3_9_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86928-2"},{"key":"e_1_3_9_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.03.239"},{"key":"e_1_3_9_55_2","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.12.4119"},{"key":"e_1_3_9_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.06.026"},{"key":"e_1_3_9_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.108786"},{"key":"e_1_3_9_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001173"},{"key":"e_1_3_9_59_2","doi-asserted-by":"publisher","DOI":"10.1177\/0284185116658683"},{"key":"e_1_3_9_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001186"},{"key":"e_1_3_9_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2020.11.028"},{"key":"e_1_3_9_62_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_306_17"},{"key":"e_1_3_9_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14442"},{"key":"e_1_3_9_64_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.32317"},{"key":"e_1_3_9_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000728"},{"key":"e_1_3_9_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05874-y"},{"key":"e_1_3_9_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.07.104"},{"key":"e_1_3_9_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.05.016"},{"key":"e_1_3_9_69_2","first-page":"3027","article-title":"Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?","volume":"35","author":"Vizzielli G","year":"2015","unstructured":"Vizzielli G, Fanfani F, Chiantera V, et al: Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy? Anticancer Res 35:3027-3032, 2015","journal-title":"Anticancer Res"},{"key":"e_1_3_9_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000860"},{"key":"e_1_3_9_71_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260255"},{"key":"e_1_3_9_72_2","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12629"},{"key":"e_1_3_9_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001534"},{"key":"e_1_3_9_74_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210091"},{"key":"e_1_3_9_75_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-7-10"},{"key":"e_1_3_9_76_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1376"},{"key":"e_1_3_9_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.07.011"},{"key":"e_1_3_9_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.015"},{"key":"e_1_3_9_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.05.012"},{"key":"e_1_3_9_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.11.520"},{"key":"e_1_3_9_81_2","doi-asserted-by":"publisher","DOI":"10.3389\/or.2022.10605"},{"key":"e_1_3_9_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep35914"},{"key":"e_1_3_9_83_2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e12"},{"key":"e_1_3_9_84_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23808"},{"key":"e_1_3_9_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10197-1"},{"key":"e_1_3_9_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv500"},{"key":"e_1_3_9_87_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3091-6"},{"key":"e_1_3_9_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.01.009"},{"key":"e_1_3_9_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00419-1"},{"key":"e_1_3_9_90_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1290719"},{"key":"e_1_3_9_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000682"},{"key":"e_1_3_9_92_2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e86"},{"key":"e_1_3_9_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17558"},{"key":"e_1_3_9_94_2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e53"},{"key":"e_1_3_9_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30566-7"},{"key":"e_1_3_9_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.06.013"},{"key":"e_1_3_9_97_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0696"},{"key":"e_1_3_9_98_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0468"},{"key":"e_1_3_9_99_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00933"},{"key":"e_1_3_9_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.03.018"},{"key":"e_1_3_9_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.11.033"},{"key":"e_1_3_9_102_2","doi-asserted-by":"publisher","DOI":"10.1159\/000535755"},{"key":"e_1_3_9_103_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001641"},{"key":"e_1_3_9_104_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000374"},{"key":"e_1_3_9_105_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2020.1787967"},{"key":"e_1_3_9_106_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133519"},{"key":"e_1_3_9_107_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-004249"},{"key":"e_1_3_9_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.08.028"},{"key":"e_1_3_9_109_2","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000469"},{"key":"e_1_3_9_110_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143556"},{"key":"e_1_3_9_111_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e17594"},{"key":"e_1_3_9_112_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12252-3"},{"key":"e_1_3_9_113_2","unstructured":"Biomarker-Kinetics: https:\/\/www.biomarker-kinetics.org\/CA-125-neo"},{"key":"e_1_3_9_114_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01296"},{"key":"e_1_3_9_115_2","doi-asserted-by":"publisher","DOI":"10.4103\/joacp.JOACP_26_18"},{"key":"e_1_3_9_116_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx754"},{"key":"e_1_3_9_117_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104390"},{"key":"e_1_3_9_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00086-8"},{"key":"e_1_3_9_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00216-3"},{"key":"e_1_3_9_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30372-3"},{"key":"e_1_3_9_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.08.041"},{"key":"e_1_3_9_122_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00542"},{"key":"e_1_3_9_123_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.2311"},{"key":"e_1_3_9_124_2","unstructured":"WHO: Social determinants of health. https:\/\/www.who.int\/health-topics\/social-determinants-of-health"},{"key":"e_1_3_9_125_2","doi-asserted-by":"publisher","DOI":"10.1200\/OP.23.00810"},{"key":"e_1_3_9_126_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02004"},{"key":"e_1_3_9_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-9684(15)30409-0"},{"key":"e_1_3_9_128_2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_350175"},{"key":"e_1_3_9_129_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-22-0542"},{"key":"e_1_3_9_130_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.7257"},{"key":"e_1_3_9_131_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01854"},{"key":"e_1_3_9_132_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-022-01660-0"},{"key":"e_1_3_9_133_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-22-0758"},{"key":"e_1_3_9_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.05.013"},{"key":"e_1_3_9_135_2","doi-asserted-by":"publisher","DOI":"10.1080\/13557858.2024.2359387"},{"key":"e_1_3_9_136_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000643"},{"key":"e_1_3_9_137_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-22-0650"},{"key":"e_1_3_9_138_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10086-y"},{"key":"e_1_3_9_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.04.009"},{"key":"e_1_3_9_140_2","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00174"},{"key":"e_1_3_9_141_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.0441"},{"key":"e_1_3_9_142_2","author":"Alpert A","year":"2021","unstructured":"Alpert A, Manzano C, Ruddick R: Degendering oncologic care and other recommendations to eliminate barriers to care for transgender people with cancer. ASCO Daily News, 2021. https:\/\/dailynews.ascopubs.org\/do\/degendering-oncologic-care-and-other-recommendations-eliminate-barriers-care","journal-title":"Degendering oncologic care and other recommendations to eliminate barriers to care for transgender people with cancer"},{"key":"e_1_3_9_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2021.03.007"},{"key":"e_1_3_9_144_2","volume-title":"Understanding Transgender People: The Basics","author":"National Center for Transgender Equality","unstructured":"National Center for Transgender Equality: Understanding Transgender People: The Basics. https:\/\/transequality.org\/issues\/resources\/understanding-transgender-people-the-basics"},{"key":"e_1_3_9_145_2","volume-title":"Terminology & Definitions","author":"UCSF Transgender Care & Treatment Guidelines","unstructured":"UCSF Transgender Care & Treatment Guidelines: Terminology & Definitions. https:\/\/transcare.ucsf.edu\/guidelines\/terminology"},{"key":"e_1_3_9_146_2","volume-title":"GRADE handbook for grading quality of evidence and strength of recommendations","author":"Sch\u00fcnemann H","year":"2013","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, et al (eds): GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group, 2013. guidelinedevelopment.org\/handbook"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO-24-02589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T17:59:37Z","timestamp":1740592777000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO-24-02589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":145,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1200\/JCO-24-02589"],"URL":"https:\/\/doi.org\/10.1200\/jco-24-02589","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}